The American Journal of Managed Care®'s annual Patient-Centered Oncology Care® conference brings together experts to deliver insights into the rapidly changing oncology care landscape.
Addressing Cancer Disparities Requires Asking Questions and Putting Aside Assumptions
September 28th 2020Speakers at Patient-Centered Oncology Care® highlighted injustices in the US health care system, the risk of financial toxicity, and how providers can do a better job to ensure their patients achieve health equity, during a panel discussion.
Read More
Dr Kerin Adelson Discusses Evolution in Physician Response to Quality Care Initiatives
September 27th 2020A gradual acceptance among physicians has been observed in adopting quality care initiatives that provide cost-saving, improved patient experience in cancer care, noted Kerin Adelson, MD, of Smilow Cancer Hospital at Yale New Haven/Yale Cancer Center.
Read More
Dr Harlan Levine on City of Hope's Efforts to Address COVID-19 in Cancer Care
September 26th 2020Testing for coronavirus disease 2019 (COVID-19) before procedures has become a fixture of City of Hope's efforts to protect patients with cancer and staff, noted Harlan Levine, MD, president of Strategy and Business Ventures at City of Hope.
Read More
Dr David Debono Details Anthem's Value-Based Strategy in Cancer Care
September 25th 2020Aligned with ASCO's Patient-Centered Oncology Payment model, Anthem has launched its value-based strategy called the oncology medical home, which seeks to promote quality metrics and improve outcome measures in cancer care.
Read More
Dr Kashyap Patel Discusses COVID-19 Implications for PCOC® 2020
September 23rd 2020The uncertainties precipitated by the coronavirus disease 2019 (COVID-19) pandemic around cancer care delivery are a challenging topic to be further addressed at this year’s Patient-Centered Oncology Care® 2020 virtual meeting.
Read More
Antonio Ciaccia Highlights Issues Within Health Care, PBM Operations for PCOC® 2020
September 15th 2020At this year's Patient-Centered Oncology Care® 2020 virtual conference, purported lack of incentives, transparency in the supply chain of pharmacy benefit manager (PBM) operations, and the overall health care system will be discussed.
Read More
Dr Harlan Levine Previews Focus of Featured Discussion at Patient-Centered Oncology Care® 2020
September 14th 2020During a featured discussion at this year’s Patient-Centered Oncology Care® 2020 virtual meeting, innovations and subsequent challenges in employing these advances within the treatment of cancer will be addressed.
Read More
Dr Karen Winkfield on Chief PCOC 2020 Message, Importance of Diversity in the Oncology Workforce
September 11th 2020Understanding each patient's individual story is vital in the transition to patient-centered care. Additionally, matching patients with physicians of the same race and background can boost comfortability among patients.
Read More
Dr Kashyap Patel on Pressing Topics in Cancer Care Delivery to Be Discussed at PCOC 2020
September 8th 2020The top 3 issues relevant within cancer care delivery to be discussed at this year's virtual Patient-Centered Oncology Care Conference 2020 will include COVID-19, pharmacy benefit managers, and alternative payment models.
Read More
Dr Joseph Alvarnas Previews Key Discussions in Oncology to Be Presented at PCOC 2020
September 8th 2020Each Patient-Centered Oncology Care meeting provides dynamic, provoking conversations on the current and future landscape of oncology. This year's PCOC 2020 will work to continue this trend.
Read More
Dr Joshua Ofman: Improving Survival, Reducing Costs in Oncology Vital to Value-Based Care Transition
February 6th 2020From a value-based medicine perspective, we think there's no greater value in the healthcare system than improving survival for cancer patients and reducing the costs of treating late stage cancer; we believe the GRAIL test could be the test case for how to make this transition, said Joshua Ofman, MD, MSHS, chief of Corporate Strategy and External Affairs at GRAIL Inc.
Read More
Rani Khetarpal Highlights the Biggest Misconception Linked With Care Pathways
January 27th 2020Pathways are not trying to restrict or take control of treating the patient from the physician, it’s actually trying to enhance that for the physician and take the guesswork of how to do that out of it, said Rani Khetarpal, MBA, vice president of Oncology Value-Based Partnerships at New Century Health.
Read More
Jennifer Atkins Explains How Blue Cross Blue Shield Evaluates Emerging Innovations in Cancer Care
January 17th 2020Blue Cross Blue Shield utilizes data to drive insights into what works and what doesn't work in cancer care, as well as, delineating trends through our collaboration with provider specialties and organizations across the US, said Jennifer Atkins, MBA, vice president of Network Solutions at Blue Cross Blue Shield.
Read More
Dr Stephen Edge Discusses the Role of Patient Reported Outcomes and Quality Metrics in Oncology Care
January 5th 2020The patient's voice is important in analyzing and evaluating the effectiveness of care, as well as in assessing the value of new treatments, said Stephen Edge, MD, FACS, FASCO, vice president of Healthcare Outcomes and Policy at Roswell Park Cancer Institute.
Read More
Rani Khetarpal Discusses Approaches by New Century Health to Manage Risk and Cost of Care
January 5th 2020Through the risk-based, capitated model it has implemented, New Century Health promotes the ability to control drug costs without jeopardizing care for the patient, said Rani Khetarpal, MBA, vice president of Oncology Value-Based Partnerships at New Century Health.
Read More
Jennifer Atkins Describes Blue Cross Blue Shield's Commitment to Innovations in Oncology
December 8th 2019Blue Cross Blue Shield is dedicated to maintaining local relationships to ensure they can provide the best care continuum to patients, said Jennifer Atkins, MBA, vice president of Network Solutions at Blue Cross Blue Shield.
Read More
Dr Joshua Ofman: Early Detection of Cancer Is Vital to the Progression of Oncology Care
November 22nd 2019GRAIL has generated enormous innovations in oncology care over the past 2 decades and will continue this trend through exploring 1 of oncology’s biggest opportunities, early detection of cancer, said Joshua Ofman, MD, chief of Corporate Strategy and External Affairs at GRAIL Inc.
Read More
Rani Khetarpal Details Early Thoughts on the Oncology Care First Model
November 13th 2019While it is too early to provide insight into whether or not the OCF model will be successful, I think its preliminary ideas are a step in the right direction, said Rani Khetarpal, MBA, vice president of Oncology Value-Based Partnerships at New Century Health.
Read More
Money, Mandate Are Keys to FDA's Drive for Use of Real-World Evidence, Gottlieb Says
November 12th 2019Former FDA Commissioner Scott Gottlieb, MD, who has returned to the American Enterprise Institute, left FDA in April after 2 whirlwind years that saw a record pace of approvals and policy actions that covered everything from high drug prices to teen vaping. He spoke Friday in Philadelphia at Patient-Centered Oncology Care®, the annual meeting of oncology reimbursement stakeholders held by The American Journal of Managed Care®.
Read More
The Fast Pace of CAR T-Cell Innovation Caused an Array of Challenges in Treatment
November 10th 2019The evidence shows that chimeric antigen receptor (CAR) T-cell therapies are effective, but the price tags on these treatments are high and have raised concerns about how many patients will get treated. During a discussion at The American Journal of Managed Care®’s Patient-Centered Oncology Care® meeting, held Friday in Philadelphia, panelists outlined the efficacy of the 2 FDA-approved therapies, Medicare reimbursement for CAR T-cell therapies, and the pace of innovation in healthcare.
Read More